Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT). - 2023
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT).
Mohty, Mohamad; Malard, Florent; Alaskar, Ahmed Set al.
2023 • In Bone Marrow Transplantation, 58 (7), p. 749 - 754
[en] Sinusoidal obstruction syndrome, also known as veno-occlusive disease (SOS/VOD), is a potentially life-threatening complication that can develop after hematopoietic cell transplantation (HCT). A new definition for diagnosis, and a severity grading system for SOS/VOD in adult patients, was reported a few years ago on behalf of the European Society for Blood and Marrow Transplantation (EBMT). The aim of this work is to update knowledge regarding diagnosis and severity assessment of SOS/VOD in adult patients, and also its pathophysiology and treatment. In particular, we now propose to refine the previous classification and distinguish probable, clinical and proven SOS/VOD at diagnosis. We also provide an accurate definition of multiorgan dysfunction (MOD) for SOS/VOD severity grading based on Sequential Organ Failure Assessment (SOFA) score.
Disciplines :
Hématologie
Auteur, co-auteur :
Mohty, Mohamad ; Hematology Department, Hôpital Saint-Antoine, and Université Pierre & Marie Curie, Paris, France. mohamad.mohty@inserm.fr
Malard, Florent ; Hematology Department, Hôpital Saint-Antoine, and Université Pierre & Marie Curie, Paris, France
Alaskar, Ahmed S ; King Abdullah International Medical Research Center/King Saud Bin Abdulaziz University for Health Sciences, Dept. of Oncology, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia
Aljurf, Mahmoud ; King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
Bader, Peter ; Division for Stem Cell Transplantation and Immunology, Department for Children and Adolescents, University Hospital, Goethe University, Frankfurt/Main, Germany
Baron, Frédéric ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie clinique
Bazarbachi, Ali ; Department of Internal Medicine, American University of Beirut, Beirut, Lebanon
Blaise, Didier ; Aix-Marseille Univ, MSC Lab, Institut Paoli-Calmettes, Department of Hematology, Marseille, France
Brissot, Eolia; Hematology Department, Hôpital Saint-Antoine, and Université Pierre & Marie Curie, Paris, France
Ciceri, Fabio ; San Raffaele Scientific Institute, Hematology and Bone marrow Transplantation Unit, Milan, Italy
Corbacioglu, Selim; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University of Regensburg, Regensburg, Germany
Dalle, Jean-Hugues ; Department of Hematology and Immunology, Hospital Robert Debre, Paris 7-Paris Diderot University, Paris, France
Dignan, Fiona; Department of Clinical Haematology, Manchester University NHS Foundation Trust, Manchester, UK
Huynh, Anne; Hematology Department, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
Kenyon, Michelle ; Department of Haematology, King's College Hospital, London, UK
Nagler, Arnon; Hematology and Bone Marrow Transplantation, Chaim Sheba Medical center, Tel-Hashomer, Israel
Pagliuca, Antonio; Department of Haematology, King's College Hospital, London, UK
Perić, Zinaida; Department of Hematology, University Hospital Centre Zagreb and School of Medicine, University of Zagreb, Zagreb, Croatia
Richardson, Paul G ; Division of Hematology, Mayo Clinic, Rochester, MN, USA
Ruggeri, Annalisa ; San Raffaele Scientific Institute, Hematology and Bone marrow Transplantation Unit, Milan, Italy
Ruutu, Tapani; Clinical Research Institute, Helsinki University Hospital, Helsinki, Finland
Yakoub-Agha, Ibrahim ; CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000, Lille, France
Duarte, Rafael F; Department of Hematology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain
Carreras, Enric; Josep Carreras Foundation & Leukemia Research Institute, (Hospital Clínic/Barcelona University Campus), Barcelona, Spain
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT).
Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M et al. Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European society for blood and marrow transplantation (EBMT). Bone Marrow Transpl. 2015; 10.1038/bmt.2015.52.
Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A, et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant. 2010;16:157–68. 10.1016/j.bbmt.2009.08.024. DOI: 10.1016/j.bbmt.2009.08.024
Richardson PG, Riches ML, Kernan NA, Brochstein JA, Mineishi S, Termuhlen AM et al. Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. Blood. 2016; 10.1182/blood-2015-10-676924.
Carreras E, Bertz H, Arcese W, Vernant JP, Tomas JF, Hagglund H, et al. Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European group for blood and marrow transplantation. Euro Group Blood Marrow Transpl Chronic Leuk Working Party. Blood. 1998;92:3599–604.
Carreras E, Diaz-Beya M, Rosinol L, Martinez C, Fernandez-Aviles F, Rovira M. The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade. Biol Blood Marrow Transpl. 2011;17:1713–20. 10.1016/j.bbmt.2011.06.006. DOI: 10.1016/j.bbmt.2011.06.006
Yakushijin K, Atsuta Y, Doki N, Yokota A, Kanamori H, Miyamoto T et al. Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes. Bone Marrow Transplant. 2015. 10.1038/bmt.2015.283.
Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, et al. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European society for blood and marrow transplantation. Bone marrow Transplant. 2016;51:906–12. 10.1038/bmt.2016.130. DOI: 10.1038/bmt.2016.130
Mohty M, Malard F, Abecasis M, Aerts E, Alaskar AS, Aljurf M, et al. Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group. Bone Marrow Transpl. 2020;55:485–95. 10.1038/s41409-019-0705-z. DOI: 10.1038/s41409-019-0705-z
Corbacioglu S, Carreras E, Ansari M, Balduzzi A, Cesaro S, Dalle JH, et al. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation. Bone marrow Transpl. 2018;53:138–45. 10.1038/bmt.2017.161. DOI: 10.1038/bmt.2017.161
Carreras E, Diaz-Ricart M. The role of the endothelium in the short-term complications of hematopoietic SCT. Bone Marrow Transpl. 2011;46:1495–502. 10.1038/bmt.2011.65. DOI: 10.1038/bmt.2011.65
Akil A, Zhang Q, Mumaw CL, Raiker N, Yu J, Velez de Mendizabal N, et al. Biomarkers for diagnosis and prognosis of sinusoidal obstruction syndrome after hematopoietic cell transplantation. Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transpl. 2015;21:1739–45. 10.1016/j.bbmt.2015.07.004. DOI: 10.1016/j.bbmt.2015.07.004
Jiang S, Penack O, Terzer T, Schult D, Majer-Lauterbach J, Radujkovic A, et al. Predicting sinusoidal obstruction syndrome after allogeneic stem cell transplantation with the EASIX biomarker panel. Haematologica. 2021;106:446–53. 10.3324/haematol.2019.238790. DOI: 10.3324/haematol.2019.238790
McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatol (Baltim, Md). 1984;4:116–22. DOI: 10.1002/hep.1840040121
Jones RJ, Lee KS, Beschorner WE, Vogel VG, Grochow LB, Braine HG, et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation. 1987;44:778–83. DOI: 10.1097/00007890-198712000-00011
Corbacioglu S, Cesaro S, Faraci M, Valteau-Couanet D, Gruhn B, Rovelli A, et al. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial. Lancet. 2012;379:1301–9. 10.1016/s0140-6736(11)61938-7. DOI: 10.1016/s0140-6736(11)61938-7
Shulman HM, Hinterberger W. Hepatic veno-occlusive disease-liver toxicity syndrome after bone marrow transplantation. Bone Marrow Transpl. 1992;10:197–214.
McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M, et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med. 1993;118:255–67. DOI: 10.7326/0003-4819-118-4-199302150-00003
Carreras E, Granena A, Navasa M, Bruguera M, Marco V, Sierra J, et al. Transjugular liver biopsy in BMT. Bone Marrow Transpl. 1993;11:21–26.
Carreras E. How I manage sinusoidal obstruction syndrome after haematopoietic cell transplantation. Br J Haematol. 2014; 10.1111/bjh.13215.
Shulman HM, Gooley T, Dudley MD, Kofler T, Feldman R, Dwyer D, et al. Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients. Transplantation. 1995;59:1015–22. DOI: 10.1097/00007890-199504150-00017
Gressens SB, Cazals-Hatem D, Lloyd V, Plessier A, Payancé A, Lebrec D, et al. Hepatic venous pressure gradient in sinusoidal obstruction syndrome: diagnostic value and link with histological lesions. JHEP Rep. 2022;4:100558 10.1016/j.jhepr.2022.100558. DOI: 10.1016/j.jhepr.2022.100558
Mahgerefteh SY, Sosna J, Bogot N, Shapira MY, Pappo O, Bloom AI. Radiologic imaging and intervention for gastrointestinal and hepatic complications of hematopoietic stem cell transplantation. Radiology. 2011;258:660–71. 10.1148/radiol.10100025. DOI: 10.1148/radiol.10100025
Lassau N, Leclere J, Auperin A, Bourhis JH, Hartmann O, Valteau-Couanet D, et al. Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and doppler US in 100 patients. Radiology. 1997;204:545–52. 10.1148/radiology.204.2.9240551. DOI: 10.1148/radiology.204.2.9240551
Brown BP, Abu-Yousef M, Farner R, LaBrecque D, Gingrich R. Doppler sonography: a noninvasive method for evaluation of hepatic venocclusive disease. AJR Am J Roentgenol. 1990;154:721–4. 10.2214/ajr.154.4.2107664. DOI: 10.2214/ajr.154.4.2107664
Nishida M, Kahata K, Hayase E, Shigematsu A, Sato M, Kudo Y, et al. Novel ultrasonographic scoring system of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2018;24:1896–1900. 10.1016/j.bbmt.2018.05.025. DOI: 10.1016/j.bbmt.2018.05.025
Tasu JP, Rocher L, PEletier G, Kuoch V, Kulh E, Miquel A, et al. Hepatic venous pressure gradients measured by duplex ultrasound. Clin Radio. 2002;57:746–52. DOI: 10.1053/crad.2002.0951
Colecchia A, Ravaioli F, Sessa M, Alemanni VL, Dajti E, Marasco G, et al. Liver stiffness measurement allows early diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome in adult patients who undergo hematopoietic stem cell transplantation: results from a monocentric prospective study. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant. 2019;25:995–1003. 10.1016/j.bbmt.2019.01.019. DOI: 10.1016/j.bbmt.2019.01.019
Debureaux PE, Bourrier P, Rautou PE, Zagdanski AM, De Boutiny M, Pagliuca S, et al. Elastography improves accuracy of early hepato-biliary complications diagnosis after allogeneic stem cell transplantation. Haematologica. 2021;106:2374–83. 10.3324/haematol.2019.245407. DOI: 10.3324/haematol.2019.245407
Poker A, Karcaaltıncaba M, Ozmen MN, Karaosmanoğlu AD, Erdemir AG, Ocal O, et al. Multiparametric MRI with MR elastography findings in patients with sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy. Insights Imaging. 2022;13:147 10.1186/s13244-022-01281-w. DOI: 10.1186/s13244-022-01281-w
Dignan FL, Wynn RF, Hadzic N, Karani J, Quaglia A, Pagliuca A, et al. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation. Br J Haematol. 2013;163:444–57. 10.1111/bjh.12558. DOI: 10.1111/bjh.12558
Yoon JH, Yoo KH, Sung KW, Jung CW, Kim JS, Hahn SM et al. Validation of treatment outcomes according to revised severity criteria from European Society for Blood and Marrow Transplantation (EBMT) for sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD). Bone Marrow Transpl. 2019; 10.1038/s41409-019-0492-6.
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. american college of chest physicians/society of critical care medicine. Chest. 1992;101:1644–55. 10.1378/chest.101.6.1644. DOI: 10.1378/chest.101.6.1644
Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the european society of intensive care medicine. Intensive Care Med. 1996;22:707–10. 10.1007/bf01709751. DOI: 10.1007/bf01709751
Kernan NA, Grupp S, Smith AR, Arai S, Triplett B, Antin JH, et al. Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome. Br J Haematol. 2018;181:816–27. 10.1111/bjh.15267. DOI: 10.1111/bjh.15267
Ruutu T, Juvonen E, Remberger M, Remes K, Volin L, Mattsson J, et al. Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized study. Biol Blood Marrow Transpl. 2014;20:135–8. 10.1016/j.bbmt.2013.10.014. DOI: 10.1016/j.bbmt.2013.10.014
Grupp SA, Corbacioglu S, Kang HJ, Teshima T, Zanette M, Lopez P, et al. A Phase 3, randomized, adaptive study of defibrotide (DF) vs best supportive care (BSC) for the prevention of hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) in patients (pts) undergoing hematopoietic cell transplantation (HCT): preliminary results. Blood. 2021;138:749 10.1182/blood-2021-147284. DOI: 10.1182/blood-2021-147284
